Ketamine and Serotonergic Psychedelics: Common Mechanisms Underlying the Effects of Rapid-Acting Antidepressants
出版年份 2020 全文链接
标题
Ketamine and Serotonergic Psychedelics: Common Mechanisms Underlying the Effects of Rapid-Acting Antidepressants
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
Volume 24, Issue 1, Pages 8-21
出版商
Oxford University Press (OUP)
发表日期
2020-11-17
DOI
10.1093/ijnp/pyaa087
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Psychedelics, but Not Ketamine, Produce Persistent Antidepressant-like Effects in a Rodent Experimental System for the Study of Depression
- (2020) Meghan Hibicke et al. ACS Chemical Neuroscience
- Psychedelics and Psychedelic-Assisted Psychotherapy
- (2020) Collin M. Reiff et al. AMERICAN JOURNAL OF PSYCHIATRY
- Modulation of amygdala reactivity following rapidly acting interventions for major depression
- (2020) Joana R. A. Loureiro et al. HUMAN BRAIN MAPPING
- Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression
- (2020) Lea J Mertens et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer
- (2020) Gabrielle I Agin-Liebes et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Evaluating global brain connectivity as an imaging marker for depression: influence of preprocessing strategies and placebo-controlled ketamine treatment
- (2020) Christoph Kraus et al. NEUROPSYCHOPHARMACOLOGY
- Electrophysiological biomarkers of antidepressant response to ketamine in treatment-resistant depression: Gamma power and long-term potentiation
- (2020) Jessica R. Gilbert et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Some Comments on Psychedelic Research
- (2020) Alan F. Schatzberg AMERICAN JOURNAL OF PSYCHIATRY
- Medial PFC AMPA receptor and BDNF signaling are required for the rapid and sustained antidepressant-like effects of 5-HT1A receptor stimulation
- (2020) Kenichi Fukumoto et al. NEUROPSYCHOPHARMACOLOGY
- Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin
- (2020) N. L. Mason et al. NEUROPSYCHOPHARMACOLOGY
- Changes in inflammatory biomarkers are related to the antidepressant effects of Ayahuasca
- (2020) Nicole Leite Galvão-Coelho et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Anxiety during ketamine infusions is associated with negative treatment responses in major depressive disorder
- (2019) Sabine Aust et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- ( R )‐Ketamine exerts antidepressant actions partly via conversion to ( 2R,6R )‐hydroxynorketamine, while causing adverse effects at sub‐anaesthetic doses
- (2019) Panos Zanos et al. BRITISH JOURNAL OF PHARMACOLOGY
- S-Ketamine Reverses Hippocampal Dendritic Spine Deficits in Flinders Sensitive Line Rats Within 1 h of Administration
- (2019) Giulia Treccani et al. MOLECULAR NEUROBIOLOGY
- Altered Connectivity in Depression: GABA and Glutamate Neurotransmitter Deficits and Reversal by Novel Treatments
- (2019) Ronald S. Duman et al. NEURON
- A single inhalation of vapor from dried toad secretion containing 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life, mindfulness-related capacities, and a decrement of psychopathological symptoms
- (2019) M. V. Uthaug et al. PSYCHOPHARMACOLOGY
- REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics
- (2019) R. L. Carhart-Harris et al. PHARMACOLOGICAL REVIEWS
- Rapid‐acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective
- (2019) Kenji Hashimoto PSYCHIATRY AND CLINICAL NEUROSCIENCES
- The influence of ketamine on drug discovery in depression
- (2019) Christoph Kraus et al. DRUG DISCOVERY TODAY
- Ketamine effects on default mode network activity and vigilance: A randomized, placebo‐controlled crossover simultaneous fMRI/EEG study
- (2019) Norman Zacharias et al. HUMAN BRAIN MAPPING
- Cortical dynamics during psychedelic and anesthetized states induced by ketamine
- (2019) Duan Li et al. NEUROIMAGE
- Effects of ketamine treatment on suicidal ideation: a qualitative study of patients’ accounts following treatment for depression in a UK ketamine clinic
- (2019) Karen Lascelles et al. BMJ Open
- Classical psychedelics for the treatment of depression and anxiety: A systematic review
- (2019) Silvia Muttoni et al. JOURNAL OF AFFECTIVE DISORDERS
- Comprehensive assessment of side effects associated with a single dose of ketamine in treatment-resistant depression
- (2019) Elia E. Acevedo-Diaz et al. JOURNAL OF AFFECTIVE DISORDERS
- Spectral signatures of serotonergic psychedelics and glutamatergic dissociatives
- (2019) Carla Pallavicini et al. NEUROIMAGE
- Distinct acute effects of LSD, MDMA, and d-amphetamine in healthy subjects
- (2019) Friederike Holze et al. NEUROPSYCHOPHARMACOLOGY
- The relationship between subjective effects induced by a single dose of ketamine and treatment response in patients with major depressive disorder: A systematic review
- (2019) David S. Mathai et al. JOURNAL OF AFFECTIVE DISORDERS
- GABA interneurons are the cellular trigger for ketamine’s rapid antidepressant actions
- (2019) Danielle M. Gerhard et al. JOURNAL OF CLINICAL INVESTIGATION
- Effects of N,N-Dimethyltryptamine on Rat Behaviors Relevant to Anxiety and Depression
- (2018) Lindsay P. Cameron et al. ACS Chemical Neuroscience
- Default Mode Connectivity in Major Depressive Disorder Measured Up to 10 Days After Ketamine Administration
- (2018) Jennifer W. Evans et al. BIOLOGICAL PSYCHIATRY
- Subanaesthetic ketamine and altered states of consciousness in humans
- (2018) P.E. Vlisides et al. BRITISH JOURNAL OF ANAESTHESIA
- A brain network model for depression: From symptom understanding to disease intervention
- (2018) Bao-Juan Li et al. CNS Neuroscience & Therapeutics
- Acute psychoactive effects of intravenous ketamine during treatment of mood disorders: Analysis of the Clinician Administered Dissociative State Scale
- (2018) Gerrit I. van Schalkwyk et al. JOURNAL OF AFFECTIVE DISORDERS
- Mechanisms of ketamine action as an antidepressant
- (2018) P Zanos et al. MOLECULAR PSYCHIATRY
- The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act
- (2018) Matthew W. Johnson et al. NEUROPHARMACOLOGY
- Evaluating the abuse potential of psychedelic drugs as part of the safety pharmacology assessment for medical use in humans
- (2018) David J. Heal et al. NEUROPHARMACOLOGY
- The effects of ketamine on prefrontal glutamate neurotransmission in healthy and depressed subjects
- (2018) Chadi G. Abdallah et al. NEUROPSYCHOPHARMACOLOGY
- Disinhibition of CA1 pyramidal cells by low-dose ketamine and other antagonists with rapid antidepressant efficacy
- (2018) Allie J. Widman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial
- (2018) Fernanda Palhano-Fontes et al. PSYCHOLOGICAL MEDICINE
- The hidden therapist: evidence for a central role of music in psychedelic therapy
- (2018) Mendel Kaelen et al. PSYCHOPHARMACOLOGY
- Psychedelics Promote Structural and Functional Neural Plasticity
- (2018) Calvin Ly et al. Cell Reports
- Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression
- (2018) Leor Roseman et al. Frontiers in Pharmacology
- Pharmacological fMRI: Effects of subanesthetic ketamine on resting-state functional connectivity in the default mode network, salience network, dorsal attention network and executive control network
- (2018) Felix Mueller et al. NeuroImage-Clinical
- Ketamine normalizes brain activity during emotionally valenced attentional processing in depression
- (2018) Jessica L. Reed et al. NeuroImage-Clinical
- Rapid inflammation modulation and antidepressant efficacy of a low-dose ketamine infusion in treatment-resistant depression: A randomized, double-blind control study
- (2018) Mu-Hong Chen et al. PSYCHIATRY RESEARCH
- Synaptic Potentiation and Rapid Antidepressant Response to Ketamine in Treatment-Resistant Major Depression: A Replication Study
- (2018) Allison C. Nugent et al. PSYCHIATRY RESEARCH-NEUROIMAGING
- Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews
- (2018) Rafael G. dos Santos et al. Expert Review of Clinical Pharmacology
- A Single Dose of 5-MeO-DMT Stimulates Cell Proliferation, Neuronal Survivability, Morphological and Functional Changes in Adult Mice Ventral Dentate Gyrus
- (2018) Rafael Vitor Lima da Cruz et al. Frontiers in Molecular Neuroscience
- Glutamatergic Neurotransmission: Pathway to Developing Novel Rapid-Acting Antidepressant Treatments
- (2018) Bashkim Kadriu et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)
- (2018) Maurizio Fava et al. MOLECULAR PSYCHIATRY
- Classic Psychedelics: An integrative review of epidemiology, mystical experience, brain network function, and therapeutics
- (2018) Matthew W. Johnson et al. PHARMACOLOGY & THERAPEUTICS
- Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor
- (2018) Katrin H Preller et al. eLife
- Ketamine and aminoguanidine differentially affect Bdnf and Mtor gene expression in the prefrontal cortex of adult male rats
- (2017) Vitor Silva Pereira et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Role of 5-HT1A Receptor Stimulation in the Medial Prefrontal Cortex in the Sustained Antidepressant Effects of Ketamine
- (2017) Kenichi Fukumoto et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Administration of ketamine for unipolar and bipolar depression
- (2017) Christoph Kraus et al. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
- Ketamine enhances structural plasticity in mouse mesencephalic and human iPSC-derived dopaminergic neurons via AMPAR-driven BDNF and mTOR signaling
- (2017) L Cavalleri et al. MOLECULAR PSYCHIATRY
- Psychiatry & the psychedelic drugs. Past, present & future
- (2017) James J.H. Rucker et al. NEUROPHARMACOLOGY
- The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future
- (2017) Robin L Carhart-Harris et al. NEUROPSYCHOPHARMACOLOGY
- Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
- (2017) R. L. Carhart-Harris et al. PSYCHOPHARMACOLOGY
- Psychedelic Drugs in Biomedicine
- (2017) Evan J. Kyzar et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin
- (2017) Michael M. Schartner et al. Scientific Reports
- Resting-state Network-specific Breakdown of Functional Connectivity during Ketamine Alteration of Consciousness in Volunteers
- (2016) Vincent Bonhomme et al. ANESTHESIOLOGY
- Inhibition of alpha oscillations through serotonin-2A receptor activation underlies the visual effects of ayahuasca in humans
- (2016) Marta Valle et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression
- (2016) Rafael Faria Sanches et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
- (2016) Roland R Griffiths et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
- (2016) Stephen Ross et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Transiently increased glutamate cycling in rat PFC is associated with rapid onset of antidepressant-like effects
- (2016) G M I Chowdhury et al. MOLECULAR PSYCHIATRY
- Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants
- (2016) Ronald S Duman et al. NATURE MEDICINE
- Ketamine Treatment and Global Brain Connectivity in Major Depression
- (2016) Chadi G Abdallah et al. NEUROPSYCHOPHARMACOLOGY
- Neural correlates of the LSD experience revealed by multimodal neuroimaging
- (2016) Robin L. Carhart-Harris et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Single-dose infusion ketamine and non-ketamine N-methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories
- (2016) T. Kishimoto et al. PSYCHOLOGICAL MEDICINE
- Effects of Ketamine on Resting-State EEG Activity and Their Relationship to Perceptual/Dissociative Symptoms in Healthy Humans
- (2016) Sara de la Salle et al. Frontiers in Pharmacology
- Psychedelics Recruit Multiple Cellular Types and Produce Complex Transcriptional Responses Within the Brain
- (2016) David A. Martin et al. EBioMedicine
- Ketamine-Induced Modulation of the Thalamo-Cortical Network in Healthy Volunteers As a Model for Schizophrenia
- (2015) Anna Höflich et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Ketamine ameliorates depressive-like behaviors and immune alterations in adult rats following maternal deprivation
- (2015) Gislaine Z. Réus et al. NEUROSCIENCE LETTERS
- Acute Biphasic Effects of Ayahuasca
- (2015) Eduardo Ekman Schenberg et al. PLoS One
- Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report
- (2015) Flávia de L. Osório et al. REVISTA BRASILEIRA DE PSIQUIATRIA
- BDNF Release Is Required for the Behavioral Actions of Ketamine
- (2015) A. E. Lepack et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- The Psychedelic State Induced by Ayahuasca Modulates the Activity and Connectivity of the Default Mode Network
- (2015) Fernanda Palhano-Fontes et al. PLoS One
- Enhanced repertoire of brain dynamical states during the psychedelic experience
- (2014) Enzo Tagliazucchi et al. HUMAN BRAIN MAPPING
- Rapid-onset antidepressant action of ketamine: potential revolution in understanding and future pharmacologic treatment of depression
- (2014) E. Drewniany et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases
- (2014) Peter Gasser et al. JOURNAL OF NERVOUS AND MENTAL DISEASE
- Chronic LSD alters gene expression profiles in the mPFC relevant to schizophrenia
- (2014) David A. Martin et al. NEUROPHARMACOLOGY
- What Did STAR*D Teach Us? Results From a Large-Scale, Practical, Clinical Trial for Patients With Depression
- (2014) Bradley N. Gaynes et al. PSYCHIATRIC SERVICES
- Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression
- (2013) C. N. Haile et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Broadband Cortical Desynchronization Underlies the Human Psychedelic State
- (2013) S. D. Muthukumaraswamy et al. JOURNAL OF NEUROSCIENCE
- Activation of Serotonin 2A Receptors Underlies the Psilocybin-Induced Effects on Oscillations, N170 Visual-Evoked Potentials, and Visual Hallucinations
- (2013) M. Kometer et al. JOURNAL OF NEUROSCIENCE
- Different effects of the NMDA receptor antagonists ketamine, MK-801, and memantine on postsynaptic density transcripts and their topography: Role of Homer signaling, and implications for novel antipsychotic and pro-cognitive targets in psychosis
- (2013) Andrea de Bartolomeis et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Default Mode Network Activity and Connectivity in Psychopathology
- (2012) Susan Whitfield-Gabrieli et al. Annual Review of Clinical Psychology
- Brain-Derived Neurotrophic Factor Val66Met Polymorphism and Antidepressant Efficacy of Ketamine in Depressed Patients
- (2012) Gonzalo Laje et al. BIOLOGICAL PSYCHIATRY
- Synaptic Potentiation Is Critical for Rapid Antidepressant Response to Ketamine in Treatment-Resistant Major Depression
- (2012) Brian R. Cornwell et al. BIOLOGICAL PSYCHIATRY
- Replication of Ketamine's Antidepressant Efficacy in Bipolar Depression: A Randomized Controlled Add-On Trial
- (2012) Carlos A. Zarate et al. BIOLOGICAL PSYCHIATRY
- Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major Depression
- (2012) James W. Murrough et al. BIOLOGICAL PSYCHIATRY
- Concomitant BDNF and sleep slow wave changes indicate ketamine-induced plasticity in major depressive disorder
- (2012) Wallace C. Duncan et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Global Connectivity of Prefrontal Cortex Predicts Cognitive Control and Intelligence
- (2012) M. W. Cole et al. JOURNAL OF NEUROSCIENCE
- Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin
- (2012) R. L. Carhart-Harris et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Brain-Derived Neurotrophic Factor Val66Met Allele Impairs Basal and Ketamine-Stimulated Synaptogenesis in Prefrontal Cortex
- (2011) Rong-Jian Liu et al. BIOLOGICAL PSYCHIATRY
- NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
- (2011) Anita E. Autry et al. NATURE
- Towards a glutamate hypothesis of depression
- (2011) Gerard Sanacora et al. NEUROPHARMACOLOGY
- A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression
- (2010) Nancy Diazgranados et al. ARCHIVES OF GENERAL PSYCHIATRY
- Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
- (2010) Charles S. Grob et al. ARCHIVES OF GENERAL PSYCHIATRY
- The neurobiology of psychedelic drugs: implications for the treatment of mood disorders
- (2010) Franz X. Vollenweider et al. NATURE REVIEWS NEUROSCIENCE
- The double edged sword of neural plasticity: Increasing serotonin levels leads to both greater vulnerability to depression and improved capacity to recover
- (2010) Igor Branchi PSYCHONEUROENDOCRINOLOGY
- mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
- (2010) N. Li et al. SCIENCE
- Brain-Derived Neurotrophic Factor and Initial Antidepressant Response to anN-Methyl-D-Aspartate Antagonist
- (2009) Rodrigo Machado-Vieira et al. JOURNAL OF CLINICAL PSYCHIATRY
- Human hallucinogen research: guidelines for safety
- (2008) MW Johnson et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine: Role of α-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic Acid Receptors
- (2007) Sungho Maeng et al. BIOLOGICAL PSYCHIATRY
- AMPA receptor involvement in 5-hydroxytryptamine2A receptor-mediated pre-frontal cortical excitatory synaptic currents and DOI-induced head shakes
- (2007) Ce Zhang et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus
- (2007) Lêda S.B. Garcia et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started